OBJECTIVE: To understand the concurrent in Toxoplasma infection among women with cervical cancer. METHODS: The anti-Toxoplasma IgG, IgM antibodies (Abs) and circulating antigens (CAg) in 247 sera (from 50 cases with cervical cancer in group 1, 59 cases with gynaecological benign tumors in group 2 and 138 cases with other diseases in group 3) were detected by ELISA. RESULTS: The total positive rates of the CAg and the Abs in the three groups were 44.0% (22/50), 25.4% (15/59) and 20.3% (28/138), respectively. The positive rates were 20.0%, 11.9% and 10.9%, respectively for IgG 20.0%, 13.6% and 8.7%, respectively for IgM and 14.0%, 5.1% and 1.4% respectively for CAg. CONCLUSION: The Toxoplasma infection rate of the cervical cancer group was higher than those of the other two groups, particularly the positive rates of CAg and IgM.
OBJECTIVE: To understand the concurrent in Toxoplasma infection among women with cervical cancer. METHODS: The anti-Toxoplasma IgG, IgM antibodies (Abs) and circulating antigens (CAg) in 247 sera (from 50 cases with cervical cancer in group 1, 59 cases with gynaecological benign tumors in group 2 and 138 cases with other diseases in group 3) were detected by ELISA. RESULTS: The total positive rates of the CAg and the Abs in the three groups were 44.0% (22/50), 25.4% (15/59) and 20.3% (28/138), respectively. The positive rates were 20.0%, 11.9% and 10.9%, respectively for IgG 20.0%, 13.6% and 8.7%, respectively for IgM and 14.0%, 5.1% and 1.4% respectively for CAg. CONCLUSION: The Toxoplasma infection rate of the cervical cancer group was higher than those of the other two groups, particularly the positive rates of CAg and IgM.